Bacterial Disease Diagnostics Market Size 2024-2028

The bacterial disease diagnostics market is forecast to increase by USD 4.34 billion and is estimated to increase at a CAGR of 6.78% between 2023 and 2028.  The market is experiencing significant expansion, driven by multiple influential factors. Firstly, the integration of digital health technology in rapid diagnostics is revolutionizing the sector, enabling faster and more accurate identification of bacterial diseases. Secondly, the high prevalence of infectious diseases worldwide necessitates the development of advanced diagnostic solutions to combat this global health concern. Lastly, the increasing trend of merger and acquisition (M&A) activities among market players is fueling growth through consolidation and innovation. These factors collectively contribute to the robust expansion of the market.

What will be the size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Market Dynamics and Customer Landscape

The market is experiencing significant advancements and growth, driven by various factors and players. Torus Biosystems leads with innovative schemes, receiving substantial funding and financial incentives. Robust infrastructure supports disease detection and monitoring, integrating personalized medicine approaches. Notably, Human Immunodeficiency Virus (HIV) detection benefits from the Minority of HIV/AIDS Fund and RNA Disease Diagnostics. Omega Specialty Nurses and House of Sophrosyne contribute to viral hepatitis care, bolstered by the CONNECT-C Grant Program. Aquaculture sector advancements target bacterial diseases in carp and mackerel, employing molecular methods like PCR and electron microscopy. Key players such as Mologic, Biogenuix, Auro Biotechnologies, Enasis Indonesia, and Thermo Fisher Scientific drive technological innovations, enhancing bacterial disease diagnostics efficacy and accessibility. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Driver

The high prevalence of infectious diseases is notably driving the infectious disease diagnostics market growth.  Globally, infectious disease outbreaks have increased due to changing lifestyles, which led to reduced immunity. The pattern of infection incidence has also been changing with the evolution of drug-resistant pathogens. The increasing prevalence of infectious diseases is expected to boost market growth as it increases the need for initiatives to increase disease awareness. Awareness campaigns about the identification of signs and symptoms of infectious diseases and methods of prevention play an important role in preventing the spread of infections.

Furthermore, the impact of these infectious diseases varies globally from region to region, with Sub-Saharan Africa, Asia Pacific, Latin America, and the Middle East getting impacted the most due to factors such as malnutrition, poor sanitation, poor water quality, and lack of proper healthcare systems. Therefore, medical professionals use bacterial disease diagnostic products such as instruments, kits, and reagents for the detection of various pathogenic organisms such as bacteria and viruses. Hence, such factors will increase the demand for bacterial disease diagnostics, which will drive the growth of the market during the forecast period.

Significant Market Trend

The growing demand for portable analytical instruments is an emerging trend in the infectious disease diagnostics market. Portable laboratory instruments are increasingly gaining prominence in the field of diagnostics owing to their ease of use. These portable instruments offer real-time, direct, and on-site measurements of inorganic and organic analytes in samples on the field, unlike conventional instruments that are ineffective on-field tools, as they do not accommodate easy movement of the instrument from the laboratory to the field. 

Portable PCR systems provide an on-site screening option to laboratory technicians and researchers. Also, these systems enable the subsequent selection of samples for routine laboratory analysis to maximize the accuracy of results. This is because the field analyst can carry the PCR systems to the site where the real-time data results are shared within hours, and the respective health or safety concerns are addressed immediately, which makes PCR systems more effective when compared with their benchtop counterparts. Furthermore, portable instruments provide a rapid and accurate diagnosis of various bacterial infections and determine the presence of antibiotic-resistant bacterial strains. Hence, such factors will augment the growth of the global infectious disease diagnostics market during the forecast period.

Major Market Challenge

The lack of accessibility to bacterial diagnostic tests in developing countries is a major challenge impeding infectious disease diagnostics market growth. High-quality diagnostic tests are easily available for various bacterial diseases in the majority of developed countries. However, they are not easily affordable or accessible in developing countries, where the disease burden is high. Management of disease by addressing symptoms is ineffective and increases the risk of antibiotic resistance. Therefore, evidence-based treatment is needed along with proper bacterial disease diagnosis for efficient disease management and developing therapies. 

A few of the barriers to the global market in developing countries include a lack of financial investment and market knowledge and support from local governments, lack of local expertise, lack of quality standards for diagnostic test evaluation and clear regulatory approvals, increased competition from companies supplying cheaper imports, and lack of cost-efficient manufacturing process, among others. Therefore, the above-mentioned issues are expected to hamper the growth of the market during the forecast period.

Market Customer Landscape

The report includes the adoption lifecycle of the infectious disease diagnostics market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Market Customer Landscape

Who are the Major Market Players?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the infectious disease diagnostics market.

QIAGEN NV -  The key offerings of the company include bacterial disease diagnostics. 

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

• Abbott Laboratories
• Accelerate Diagnostics Inc.
• Becton Dickinson and Co.
• Bio Rad Laboratories Inc.
• bioMerieux SA
• Bruker Corp.
• Danaher Corp.
• DiaSorin SpA
• EKF Diagnostics Holdings Plc
• F. Hoffmann La Roche Ltd.
• GENERI BIOTECH s.r.o.
• Great Basin Scientific
• Hologic Inc.
• Meridian Bioscience Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segment in the Market?

The market share growth by the consumables segment will be significant during the forecast period. The consumables segment comprises test kits, assays, and reagents used for the quantification of bacterial diseases. It contributes significantly to the market growth due to the repetitive purchase of a broad range of PCR consumables for different testing purposes.

Get a glance at the market contribution of various segments Request a PDF Sample

The consumables segment was valued at USD 4.60 billion in 2018 and continued to grow until 2022.  End-users use consumables such as reagents and buffers repeatedly to conduct tests and experiments. Various applications require a variety of reagents based on the purpose of testing, which provides an opportunity for PCR consumables manufacturers to offer a broad range of consumables to meet the testing requirements of end-users. The high demand for consumables is further augmented by the ever-changing consumer demands, resulting in shifting diagnostic testing from hospitals and laboratories to patients' homes, which reduces the cost of testing. Furthermore, technological advances in reaction buffers have provided greater stability and longer activity for reagents and enzymes, which resulted in enhancing the value of PCR and reverse transcription-polymerase chain reaction (RT-PCR) techniques. In addition, advances in the microarray, which provides the genetic (deoxyribonucleic acid (DNA) analysis in a short period, have contributed to the success of testing and experimenting. Therefore, such factors are anticipated to drive the growth of the market during the forecast period. 

Which are the Key Regions for the Market?

For more insights on the market share of various regions Request PDF Sample now!

North America is estimated to contribute 54% to the growth of the global infectious disease diagnostics market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The US is the leading contributor to the market in North America, owing to the growing focus on the treatment of bacterial diseases such as TB. The major factors associated with the market growth in North America are the increase in the prevalence of bacterial diseases such as TB, meningitis, and pneumonia. Respiratory tract infections caused by bacteria are among the most common conditions in human beings and are associated with a high economic burden. In Canada, researchers have developed new methods to diagnose a bacterial infection.

For instance, the University of British Columbia Okanagan campus and the University of Calgary for the development of a diagnostic tool that aids healthcare practitioners in performing on-spot diagnosis of a bacterial infection. It offers a rapid, label-free, and contactless diagnosis and also screens the interaction of bacteria with antibiotics. Moreover, the total healthcare spending in Canada increased significantly and reached approximately USD 515 billion by the first half of 2022. Furthermore, there is a significant increase in the prevalence of chronic diseases in the region. The development of such diagnostic tests will be helpful for patients with chronic infections, which in turn, will fuel the market growth during the forecast period. 

Segment Overview

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.

• Product Outlook 
  • Consumables
  • Instruments

• End-user Outlook 
  • Hospitals
  • Labs

• Region Outlook 
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
    • Vietnam
    • Others
  • Rest of World
    • Saudi Arabia
    • South Africa
    • Brazil
    • Others

You may also interested in below market reports:

• Infectious Disease Diagnostics Market: Infectious Disease Diagnostics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast
•  Infectious Disease Market: Infectious Disease Market by Product, End-user, and Geography - Forecast and Analysis 
• Microbiology Testing Market: Microbiology Testing Market Method, Product, End-user, and Geography - Forecast and Analysis

Market Analyst Overview

The Market is a critical sector characterized by schemes and funding initiatives aimed at addressing infrastructure needs and enhancing disease detection and monitoring capabilities. Financial incentives drive advancements in personalized medicine, particularly for diseases like Tuberculosis, HIV/AIDS, Hepatitis, and respiratory infections. Control measures are paramount, especially amidst declining reimbursement scenarios and budgetary concerns, impacting the patient population and medical tourism trends. Data requirements pose operational barriers for clinical laboratories involved in procurement, storage, and transportation of specimens. The market landscape depends on the Human Immunodeficiency Virus, Omega Specialty Nurses, House of Sophrosyne, Viral Hepatitis Care Network, CONNECT-C Grant Program, PCR methods, Biogenuix, Enasis Indonesia. Next-Generation Sequencing and Lab-on-a-chip PCR devices revolutionize pathogen detection, mitigating risks of cross-contamination while enhancing time efficiency. Software and services play a vital role in enhancing versatility and reliability in testing needs.

Additionally, hospital-acquired infections and sexually transmitted diseases like Chlamydia trachomatis, Neisseria gonorrhea, and HPV necessitate stringent containment measures. Automated platforms and high-throughput systems from key players like Mylab Discovery Solutions, BioMedomics, and Thermo Fisher Scientific aid in rapid diagnosis. The Minority of HIV/AIDS Fund, RNA Disease Diagnostics, and other initiatives contribute to combating infectious illnesses. In the aquaculture sector, molecular methods, including PCR techniques and electron microscopy, enhance disease diagnostics for seafood like Carp and Mackerel. Companies like Mologic and Auro Biotechnologies lead in providing medical products for food security and nutrition, including water purification techniques, probiotics, and antibiotic treatments.

Request PDF sample

What are the Key Data Covered in this Market Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the market between 2023 and 2028
• Precise estimation of the market size and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive market forecast analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this report to meet your requirements. Get in touch